Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (FRA:FDY)

Germany flag Germany · Delayed Price · Currency is EUR
0.3100
+0.0100 (3.33%)
At close: Mar 27, 2026
Market Cap814.15M -4.2%
Revenue (ttm)83.51M -3.3%
Net Income-19.17M
EPS-0.02
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.3100
Previous Close0.3000
Day's Range0.3100 - 0.3100
52-Week Range0.3000 - 0.3660
Betan/a
RSI43.96
Earnings DateMar 30, 2026

About FRA:FDY

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China. It offers genetic engineering platform drugs, including Trop2-SN38 ADC that is in Phase III clinical trials for Triple-negative breast cancer; CD30-DM1 antibody-drug conjugate (ADC), which have complected Phase I clinical trials for tumors; Trop2-BB05 ADC that is in Phase I clinical trial for tumors; DLL3-BB05 ADC, which is in phase I clinical trial for tumors; and H... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1996
Employees 923
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol FDY

Financial Performance

Financial numbers in CNY Financial Statements